InsidersTradesSigma
Track the Novo Integrated Sciences, Inc. share price and the full directors' dealings record of the company, a listed issuer based in United States. Shares trade on the US market, under the oversight of SEC (Form 4). Operating in the Health Care sector, Novo Integrated Sciences, Inc. has logged 1 public disclosures. Market capitalisation: €77k. The latest transaction was disclosed on 21 April 2022 (Acquisition). Among the most active insiders: Oliva Robert Letterio. The full history is accessible without an account.
1
Insider Decl.
n/a
Thresholds
€10,306
1 ops.
Buy Volume
n/a
n/a
Sell Volume
26Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 21 April 2022
Declarations1 total
5,000 shares@ US$2.2250.0000% mcap100.0% of flowCommon StockSEC:0001493152-22-010621:0
Canonical exit: 18 Jul 2022 (T+90)
1 of 1 declaration
关于 Novo Integrated Sciences, Inc.
Novo Integrated Sciences, Inc. 是一家专注于健康和制药领域的公司。它致力于开发创新解决方案，以增进患者的健康和福祉。